Published in Eur J Pharmacol on February 01, 1978
The relative toxicity of amitriptyline, imipramine, maprotiline and mianserin in rabbits in vivo. Br J Pharmacol (1979) 0.75
Proceedings of the British Pharmacological Society. 10th-12th September, 1980. Abstracts. Br J Pharmacol (1981) 0.75
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Central adrenergic neurones and the initiation and development of experimental hypertension. Experientia (1972) 1.67
Carotid sinus syndrome and embolization procedures. AJNR Am J Neuroradiol (1993) 1.45
Central hypertensive action of histamine in conscious normotensive cats. Eur J Pharmacol (1976) 1.40
The contribution of the sympathetic nervous system to the development and maintenance of experimental hypertension in the rat. Br J Pharmacol (1970) 1.34
The cardiovascular effects of intraventricular clonidine and Bay 1470 in conscious hypertensive cats. Br J Pharmacol (1974) 1.33
The cardiovascular effects of intraventricularly administered histamine in the anaesthetised rat. Naunyn Schmiedebergs Arch Pharmacol (1976) 1.26
Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. Br J Pharmacol (1973) 1.25
The effect of bilateral adrenal demedullation on vascular reactivity and blood pressure in spontaneously hypertensive rats. Br J Pharmacol (1983) 1.15
Description and application of a system for locomotor rehabilitation. Med Biol Eng Comput (1987) 1.13
Adrenaline and the development of spontaneous hypertension in rats. J Auton Pharmacol (1985) 1.12
Studies on the hypotensive action of alpha-methyldopamine. Br J Pharmacol (1975) 1.06
Preoperative embolization of cerebral arteriovenous malformations with silk sutures: analysis and clinical correlation of complications revealed on computerized tomography scanning. J Neurosurg (2000) 1.05
Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.03
Cardiovascular reactivity in the experimental hypertensive rat. Br J Pharmacol (1971) 1.02
The central hypotensive action of clonidine and BAY 1470 in cats and rats. Clin Sci Mol Med Suppl (1975) 1.02
No evidence for central histamine-receptor involvement with the hypotensive effect of clonidine in cats. Eur J Pharmacol (1976) 1.01
Transcutaneous electrical nerve stimulation for low back pain. A comparison of TENS and massage for pain and range of motion. Phys Ther (1983) 1.01
On the mechanisms of kappa-opioid-induced diuresis. Br J Pharmacol (1986) 1.01
Effects of 6-hydroxydopamine on the perfused rat mesentery preparation. J Pharm Pharmacol (1970) 0.97
The cardiovascular effects of apomorphine in the anaesthetized rat. Eur J Pharmacol (1973) 0.97
Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol Appl Pharmacol (1998) 0.96
A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat. J Pharm Pharmacol (1970) 0.96
Epinephrine enhances neurogenic vasoconstriction in the rat perfused kidney. Hypertension (1985) 0.94
The role of the sympathetic nervous system in the cardiovascular responses to angiotensin in the pithed rat. Br J Pharmacol (1969) 0.93
Clonidine-induced hypotension: further evidence for a central interaction with histamine H2 receptor antagonists in the rat. Neuropharmacology (1978) 0.92
Vascular resistance and reactivity in hypertensive rats. Blood Vessels (1974) 0.91
A centrally acting antihypertensive agent (R28935) not mediated via central alpha-adrenoreceptors. Eur J Pharmacol (1976) 0.90
Receptor-mediated elimination of phosphocholine-specific B cells in x-linked immune-deficient mice. J Immunol (1991) 0.90
Proceedings: Failure to induce experimental hypertension in rats after intraventricular injection of 6-hydroxydopamine. Br J Pharmacol (1972) 0.90
Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine. Br J Pharmacol (1973) 0.89
Studies on the rebound hypertension after clonidine withdrawal in conscious hypertensive cats, rats, and dogs [proceedings]. Br J Pharmacol (1977) 0.89
Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada. Osteoporos Int (2013) 0.88
Interaction between histamine H2-receptor antagonists and the hypotensive effects of clonidine in rats [proceedings]. Br J Pharmacol (1977) 0.88
Combined effect of neonatal sympathectomy and adrenal demedullation on blood pressure and vascular changes in spontaneously hypertensive rats. Circ Res (1991) 0.87
A comparison of the cardiovascular effects of centrally administered clonidine and adrenaline in the anaesthetized rat. J Pharm Pharmacol (1979) 0.86
Proceedings: The recovery of vascular adrenergic nerve function in the rat after chemical sympathectomy with 6-hydroxydopamine. Br J Pharmacol (1972) 0.86
Vascular reactivity in hypertensive rats after treatment with anti-hypertensive agents. Life Sci (1974) 0.86
Does the adrenal medulla contribute to the maintenance of experimental hypertension? Eur J Pharmacol (1970) 0.85
The alpha 1- and alpha 2-adrenoceptor involvement in the central cardiovascular action of clonidine in the conscious renal hypertensive cat. Eur J Pharmacol (1982) 0.83
An increased reactivity in hypertensive rats unaffected by prolonged antihypertensive therapy. Br J Pharmacol (1975) 0.83
Beta 2-adrenoceptors mediate adrenaline's facilitation of neurogenic vasoconstriction. Eur J Pharmacol (1984) 0.83
The neurogenic component in the experimental hypertensive rat. Pharmacology (1971) 0.82
Genetic aspects of variability in superficial vein responsiveness to norepinephrine. Clin Pharmacol Ther (1991) 0.82
An altered beta-adrenoreceptor-mediated modulation of noradrenaline-induced vasoconstriction in spontaneously hypertensive rat mesenteric arteries. J Auton Pharmacol (1984) 0.81
Facilitation by beta-adrenoreceptors of stimulation-induced vasoconstriction in pithed spontaneously hypertensive rats. J Auton Pharmacol (1984) 0.81
Proceedings: Studies on the central hypotensive effects of clonidine. J Pharm Pharmacol (1973) 0.81
Proceedings: Central hypertensive action of histamine in rats. Br J Pharmacol (1975) 0.81
Evidence for a central alpha-sympathomimetic action of clonidine in the rat. J Pharm Pharmacol (1975) 0.80
The cardiovascular effects of intraventricular 5,6-dihydroxytryptamine in conscious hypertensive rats. Clin Exp Pharmacol Physiol (1978) 0.80
Involvement of hypothalamic histamine-receptors in the central cardiovascular actions of histamine. Neuropharmacology (1977) 0.79
Postsynaptic spinal alpha-adrenoceptors mediate effects of intrathecal clonidine. Eur J Pharmacol (1981) 0.79
Cardiovascular changes in anaesthetised rats after the intra-hypothalamic administration of adrenaline. Clin Exp Hypertens (1978) 0.79
Human insulin-mediated enhancement of vascular beta-adrenergic responsiveness. Hypertension (1994) 0.78
The regional hydrolysis of ethyl acrylate to acrylic acid in the rat nasal cavity. Toxicol Lett (1994) 0.78
Pharmacological characteristics of spinal alpha-adrenoreceptors in rats. J Auton Pharmacol (1981) 0.78
A comparison of the effects of chemical sympathectomy by 6-hydroxydopamine in newborn and adult rats. Br J Pharmacol (1973) 0.77
Metabolism of acrylic acid to carbon dioxide in mouse tissues. Fundam Appl Toxicol (1993) 0.77
Cardiovascular withdrawal effects of clonidine and tiamenidine on abrupt cessation of oral treatment in conscious cats. J Pharm Pharmacol (1980) 0.76
Cardiovascular responses to centrally administered adrenaline in spontaneous hypertensive rats [proceedings]. Br J Pharmacol (1977) 0.76
Characterization of a novel rat thymocyte costimulating antigen by the monoclonal antibody 1.3. J Immunol (1992) 0.76
Glutathione content and turnover in rat nasal epithelia. Toxicol Appl Pharmacol (1995) 0.76
Serum insulin-like growth factor-I (IGF-I) does not correlate positively with isometric strength, fatigue, and quality of life in post-polio syndrome. J Neurol Sci (2001) 0.76
Proceedings: Hypotensive action of alpha-methyldopamine. Br J Pharmacol (1975) 0.75
Investigations into the role of spinal alpha-adrenoceptors in cardiovascular modulation in rats [proceedings]. Br J Pharmacol (1980) 0.75
Proceedings: Studies on the centrally mediated cardiovascular effects of apomorphine in the anaesthetized rat. Br J Pharmacol (1976) 0.75
Proceedings: An increased reactivity in hypertensive animals after prolonged antihypertensive therapy. Br J Pharmacol (1974) 0.75
Studies on the marked antihypertensive properties of indapamide (SE 1520) in rats and cats [proceedings]. Br J Pharmacol (1976) 0.75
Proceedings: A centrally-acting antihypertensive agent R28935, a pimozide analogue, not acting via alpha-adrenergic neurones. Br J Pharmacol (1975) 0.75
The effect of adrenal demedullation on cardiovascular responses to environmental stimulation in conscious rats. Br J Pharmacol (1986) 0.75
Further evidence for a central hypotensive action of -methyldopa. Br J Pharmacol (1972) 0.75
Adrenaline and the development of genetic hypertension. J Hypertens Suppl (1984) 0.75
Interaction between sympathetic nervous system and adrenal medulla in the control of cardiovascular changes in hypertension. J Cardiovasc Pharmacol (1991) 0.75
Effects of 6-hydroxydopamine at birth on the development of hypertension in the rat. Life Sci (1973) 0.75
Beta-adrenoreceptor-mediated modulation of vasoconstriction in rat isolated perfused mesenteric arteries. J Auton Pharmacol (1983) 0.75
MJ Care never gives up. Rehab Manag (2005) 0.75
Clonidine-induced potentiation of reflex vagal bradycardia in anaesthetized cats. J Pharm Pharmacol (1982) 0.75
Validation of indirect systolic blood pressure measurement in ether anaesthetised rats. J Auton Pharmacol (1983) 0.75
Twin calves, total artificial heart, cardiac transplantation. Artif Organs (1983) 0.75
Molding a symbiotic partnership. Rehab Manag (2001) 0.75
Raising the standards. Rehab Manag (2000) 0.75
Acrylic acid oxidation and tissue-to-blood partition coefficients in rat tissues. Toxicol Lett (1995) 0.75
Changes in vascular reactivity in experimental hypertensive animals following treatment with indapamide. J Pharm Pharmacol (1977) 0.75
Superficial hydradenoma of the cheek. Br J Oral Surg (1973) 0.75
Disposition and metabolism of acrylic acid in C3H mice and Fischer 344 rats after oral or cutaneous administration. J Toxicol Environ Health (1995) 0.75
The distribution of NPY-containing nerves and the catecholamine contents of canine enteric nerve plexuses. Peptides (1997) 0.75